Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.
Saved in:
| Title: | Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. |
|---|---|
| Authors: | Viale, G.1, Regan, M. M.2, Dell'Orto, P.1, Mastropasqua, M. G.1, Maiorano, E.3, Rasmussen, B. B.4, MacGrogan, G.5, Forbes, J. F.6, Paridaens, R. J.7, Colleoni, M.8, Láng, I.9, Thürlimann, B.10, Mouridsen, H.11, Mauriac, L.12, Gelber, R. D.2, Price, K. N.2, Goldhirsch, A.8,13, Gusterson, B. A.14, Coates, A. S.15 |
| Source: | Annals of Oncology. Oct2011, Vol. 22 Issue 10, p2201-2207. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 66141757 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Viale%2C+G%2E%22">Viale, G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Regan%2C+M%2E+M%2E%22">Regan, M. M.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Dell'Orto%2C+P%2E%22">Dell'Orto, P.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Mastropasqua%2C+M%2E+G%2E%22">Mastropasqua, M. G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Maiorano%2C+E%2E%22">Maiorano, E.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Rasmussen%2C+B%2E+B%2E%22">Rasmussen, B. B.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22MacGrogan%2C+G%2E%22">MacGrogan, G.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Forbes%2C+J%2E+F%2E%22">Forbes, J. F.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Paridaens%2C+R%2E+J%2E%22">Paridaens, R. J.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Colleoni%2C+M%2E%22">Colleoni, M.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Láng%2C+I%2E%22">Láng, I.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Thürlimann%2C+B%2E%22">Thürlimann, B.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Mouridsen%2C+H%2E%22">Mouridsen, H.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Mauriac%2C+L%2E%22">Mauriac, L.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Gelber%2C+R%2E+D%2E%22">Gelber, R. D.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Price%2C+K%2E+N%2E%22">Price, K. N.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Goldhirsch%2C+A%2E%22">Goldhirsch, A.</searchLink><relatesTo>8,13</relatesTo><br /><searchLink fieldCode="AR" term="%22Gusterson%2C+B%2E+A%2E%22">Gusterson, B. A.</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Coates%2C+A%2E+S%2E%22">Coates, A. S.</searchLink><relatesTo>15</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Oct2011, Vol. 22 Issue 10, p2201-2207. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=66141757 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 2201 Titles: – TitleFull: Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Viale, G. – PersonEntity: Name: NameFull: Regan, M. M. – PersonEntity: Name: NameFull: Dell'Orto, P. – PersonEntity: Name: NameFull: Mastropasqua, M. G. – PersonEntity: Name: NameFull: Maiorano, E. – PersonEntity: Name: NameFull: Rasmussen, B. B. – PersonEntity: Name: NameFull: MacGrogan, G. – PersonEntity: Name: NameFull: Forbes, J. F. – PersonEntity: Name: NameFull: Paridaens, R. J. – PersonEntity: Name: NameFull: Colleoni, M. – PersonEntity: Name: NameFull: Láng, I. – PersonEntity: Name: NameFull: Thürlimann, B. – PersonEntity: Name: NameFull: Mouridsen, H. – PersonEntity: Name: NameFull: Mauriac, L. – PersonEntity: Name: NameFull: Gelber, R. D. – PersonEntity: Name: NameFull: Price, K. N. – PersonEntity: Name: NameFull: Goldhirsch, A. – PersonEntity: Name: NameFull: Gusterson, B. A. – PersonEntity: Name: NameFull: Coates, A. S. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2011 Type: published Y: 2011 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 22 – Type: issue Value: 10 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |